BioArctic AB (BRCTF) reports robust financial performance and advances in Alzheimer's treatment, while navigating market access hurdles and rising operational costs.

Net Revenue: $507.1 million, a year-on-year decline of 2.4%. EBITDA: $336.9 million with an EBITDA margin of 66.4%. Live Revenue: Declined by 3.4% to $431.7 million. RNG Revenue: Increased by 4.2% to ...

Link: https://www.zacks.com/commentary/2466368/4-metal-fabrication-stocks-to-watch-amid-improving-industry-trends The Zacks Metal Products - Procurement and ...